BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30951626)

  • 1. Treatment of the facial basal cell carcinoma with the use of photodynamic therapy: A case report.
    Trafalski M; Kazubowska K; Jurczyszyn K
    Dent Med Probl; 2019; 56(1):105-110. PubMed ID: 30951626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
    Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
    Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer.
    Marmur ES; Schmults CD; Goldberg DJ
    Dermatol Surg; 2004 Feb; 30(2 Pt 2):264-71. PubMed ID: 14871220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular preservation through limited tumor excision combined with ALA-PDT in patients with periocular basal cell carcinoma.
    Li X; Tan L; Kou H; Zhang J; Wang Y; Li G; Lu Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():291-294. PubMed ID: 31233885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plum-blossom needling enhanced the effect of photodynamic therapy on basal cell carcinoma.
    Mu X; Wang L; Wang L; Ge R; Dang H; Mou K
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():339-341. PubMed ID: 30077651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma.
    Smucler R; Vlk M
    Lasers Surg Med; 2008 Feb; 40(2):153-8. PubMed ID: 18306163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
    Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O
    Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic diagnosis and photodynamic therapy in basal cell carcinoma using a novel laser light source.
    Woźniak Z; Trzeciakowski W; Chlebicka I; Ziółkowski P
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101883. PubMed ID: 32574799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
    Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
    Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Photodynamic therapy of nasal basal cell carcinoma].
    Haddad R; Cohen M; Kaplan O; Greenberg R; Kashtan H
    Harefuah; 2001 Jan; 140(1):25-7, 86. PubMed ID: 11242893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
    Cosgarea R; Susan M; Crisan M; Senila S
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions.
    Themstrup L; Banzhaf CA; Mogensen M; Jemec GB
    Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):7-12. PubMed ID: 24280439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma.
    Caekelbergh K; Annemans L; Lambert J; Roelandts R
    Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
    Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
    Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.